
Keywords: lung cancer; diagnostic test; biomarkers; prediction models; risk prediction; CT; computed tomography; EDTA; ethylenediaminetetraacetic acid; FDG; fluorodeoxyglucose; NPV; negative predictive value; NSCLC; non-small cell lung cancer; PET; positron emiss